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Bioresorbable three-dimensional scaffolds have special applications in tissue engineering 
and have been fabricated using different processing techniques. The key to an ideal tissue 
engineering scaffold might depend on the ability to fabricate scaffolds with suitable shape 
and inner structure while having the necessary biocompatibility properties for different 
applications. 
In this research, rapid prototyping technology is applied to fabricate 3D scaffolds for 
tissue engineering by using a specially developed desktop RP system. This desktop RP 
system is a computer-controlled four-axis machine with a multiple-dispenser head. The 
material used in this study is chitosan dissolved in acetic acid and sodium hydroxide 
solution. Neutralization of the acetic acid by the sodium hydroxide results in a precipitate 
to form gel-like chitosan strands. 
Free-form scaffolds have been built from relevant features extracted from given CT-scan 
images by this system. The required geometric data for the scaffolds in the form of a 
solid model can be derived from the CT-scan images through the use of a software to 
reconstruct images taken from CT/MR into a 3D model and converting the data to the 
data formats that can be recognized by rapid prototyping systems. The reconstructed 
computer model is sliced into consecutive two-dimensional layers to generate 
appropriately formatted data for the desktop RP system to fabricate the scaffolds. The 
four-axis system enables strands to be laid in a different direction at each layer to form 
suitable interlacing 3D free-form scaffold structures. 
Summary 
 vi
Results from scanning electron microscopy and in-vitro cell seeding showed suitable 
structure as well as cell compatibility and attachment of the chitosan scaffolds built by 
the RP system. The study indicated that this RP system has the ability to fabricate 3D 
free-form scaffolds and the built scaffolds have potential for use in tissue engineering 
applications. 
 
Keywords:  Rapid Prototyping, 3D Scaffold, Tissue Engineering, Chitosan, 
Biocompatibility 
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Chapter 1  
Introduction 
 
1.1 Tissue Engineering 
The need to produce tissues and organs for organ transplant due to the acute 
shortage of tissues and organs [Mooney and Mikos, 1999], and a possible mismatch 
of tissue types that can result in organ rejection, astronomical drug therapy costs and 
the potential development of cancer [Mrunal, 2000], brought about the birth of tissue 
engineering in the late 1980s [Berthiaume and Yarmush, 1995]. During a National 
Science Foundation workshop in 1988, tissue engineering was formally defined as 
[Lewis, 1995]: “The application of principles and methods of engineering and life 
sciences towards fundamental understanding of structure-function relationships in 
normal and pathological mammalian tissues and the development of biological 
substitutes to restore, maintain or improve tissue functions.” Still in its infant stage, 
tissue engineering is intensively researched into to provide for the implantation of an 
engineered substitute for tissue loss or end-stage organ failure resulting from a disease 
or an injury. It provides a better alternative to the standard tissues or organ transplant 
with donated organs. 
Generally, there are three strategies that are utilized in tissue engineering 
[Chaignaud et al., 1997]: (1) the replacement of only isolated cells or cell substitutes 
needed for function; (2) the production and delivery of tissue-inducing substances 
such as growth factors and signal molecules; (3) the use of a scaffold (matrix) made 
from synthetic polymers or natural substances to promote cell proliferation. 
 




Perhaps the most challenging and promising strategy of tissue engineering is 
the in-vitro generation of autologous tissues by using cells isolated from donor tissues 
in combination with a scaffold. The success of such an approach offers the possibility 
of growing functional new tissues and even organs entirely in a laboratory 
environment. 
In the study conducted by Vacanti et al. [1988], it was observed that 
dissociated cells tend to organize themselves to form a tissue structure when they 
were provided with a guiding template. Therefore, the modern approach in tissue 
engineering utilizes 2D or porous 3D scaffolds, composed of biodegradable natural or 
synthetic polymers, to provide a temporary substrate to which transplanted cells could 
adhere, proliferate and differentiate, in order that a functional tissue can be 
regenerated. 
In this scaffold-based tissue engineering strategy, the successful regeneration 
of tissue and organs relies on the fabrication and application of suitable scaffolds.  
Different processing techniques have been developed to build TE scaffolds. 
Conventional scaffold fabrication techniques include fiber bonding [Brauker et al., 
1995], phase separation [Ma and Zhang, 1999], solvent casting/particulate leaching 
[Mikos et al., 1993], membrane lamination [Mikos et al., 1996], melt molding 
[Thomson et al., 1995], gas foaming/high pressure processing [Baldwin et al., 1995], 
hydrocarbon templating [Shastri et al., 1997], freeze drying [Healy et al., 1998] and 
combinations of these techniques (e.g., gas foaming/particulate leaching [Harris et 
al.,1998], etc.). However, most of them are limited by some forms of flaws that 
include inconsistent and inflexible processing procedures, use of toxic organic 
solvents, manual intervention, and shape limitations. Therefore, the scope of their 
applications is restricted by these drawbacks. 




On a separate front, the introduction of rapid prototyping (RP) technologies 
starts a new revolutionary era for product design and manufacturing industries. The 
RP technology enables quick and easy transition from concept generation in the form 
of computer models to the fabrication of physical models. Developed to shorten and 
simplify the product development cycle, the flexibility and outstanding manufacturing 
capabilities of RP have already been employed for biomedical applications, especially 
scaffold fabrication.  Its immense potential for producing highly complex macro- and 
microstructures is widely recognized and studied by many researchers in the 
manufacturing of TE scaffolds. At present, several RP techniques have been exploited 
for scaffold fabrication, such as fused deposition modeling (FDM) [Hutmacher et al., 
2000], 3D printing (3DP) [Kim et al., 1998] and SLS [Lee and Barlow, 1994]. 
Landers and co-workers [2002] reported the development of a 3D plotting RP 
technology to meet the demands for desktop fabrication of hydrogel scaffolds. A key 
feature of this RP technology is the 3D dispensing of liquids and pastes in liquid 
media. This RP process prepared scaffolds with a designed external shape and a well-
defined porous structure. A fabrication process that resembles the technology reported 
by Landers [2002] has been adopted to build scaffolds using a specially developed 
rapid prototyping robotic dispensing (RPBOD) system by researchers at the National 
University of Singapore [Ang et al., 2002]. This RPBOD system was developed from 
a computer-guided desktop robot (Robokids, Sony), which is capable of three 
simultaneous translational movements along the X-, Y- and Z-axis. 
The scaffolds fabricated by the RPBOD system showed good attachment 
between layers, which allowed the matrix to form fully interconnected channel 
architecture, and results of in-vitro cell culture studies revealed the biocompatibility 




of the scaffolds. Ang et al. [2002] demonstrated the potential of the RPBOD system in 
fabricating 3D TE scaffolds with regular and reproducible macropore architecture. 
The RPBOD system was subsequently improved by using a new fabrication 
method, referred to as dual dispensing [Tan, 2002]. A rotary motion about the Z-axis 
of the base was added. A multiple-dispenser unit was incorporated to the RPBOD 
system with two kinds of dispensing mechanisms: pneumatic and mechanical. 
Building of the scaffolds with the desktop RPBOD system has been developed based 
on the sequential dispensing of chitosan dissolved in acetic acid and sodium 
hydroxide solution. Neutralization of the acetic acid by the sodium hydroxide results 
in a precipitate to form a gel-like chitosan strand. The four-axis system enables 
strands to be laid in a different direction at each layer to form suitable interlacing 3D 
scaffold structures layer by layer. 
1.2 Research Objectives 
Based on the previous research, the objectives of this research are: 
I. To optimize the parameters and conditions for fabricating scaffolds by 
the dual dispensing method with the RPBOD system. 
II. To design and fabricate 3D free-form scaffolds with relevant features 
extracted from given medical images (CT/ MRI) using a desktop PC. 
III. To characterize the built scaffolds and evaluate their potential for 
application in tissue engineering. 
1.3 Research Scope 
In the first phase of this research, experiments were carried out to determine 
set of optimized parameters of the fabrication process. At the same time, protocols for 




the preparation of materials for scaffold fabrication were established based on the 
material properties.  In the free-form scaffold fabrication phase, the data conversion 
process was developed to transfer medical data (CT/MRI) to the appropriate RP-
compatible data format. This involves the use of a software to reconstruct images 
taken from CT/MR into 3D model and convert the data to the format that can be 
recognized by the developed rapid prototyping systems. Geometric data of the 
scaffold was generated based on the computer model built from the medical data. 
During the scaffold characterization and analysis phase, scanning electron microscopy 
(SEM) was used for scaffold morphology analysis. Porosity and density of the built 
scaffolds were calculated and compression tests were conducted to evaluate their load 
capacity. The biocompatibility of the scaffolds was studied by cell seeding. 
1.4 Thesis Outline 
After an overall introduction of this chapter, the rest of this thesis is organized 
as follows: 
Chapter 2 provides a literature review on TE scaffold, rapid prototyping and 
RP-related scaffold fabrication techniques. 
Chapter 3 investigates the biomaterials used in TE scaffolds, selects the 
materials and the procedure for material preparation in this research and briefly 
presents the methods to fabricate scaffolds and the experiments carried out to 
characterize the scaffolds. 
Chapter 4 gives a general outline of the RPBOD system and details with the 
manufacturing process of regular shape and irregular scaffolds using the dual 
dispensing method. 




Chapter 5 presents the experimental results and discusses the advantages and 
improvements of the dual dispensing fabrication method and potential of the PRBOD 
system to desktop manufacture for TE scaffolds. 
Chapter 6 concludes and recommends for future research. 
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Chapter 2  
Literature Review 
 
Since scaffolds serve a very important role in TE, there are plenty of existing 
works about the TE scaffold manufacturing in the literature. Section 2.1 reviews the 
general applications of TE scaffolds in medical area. Section 2.2 examines the 
traditional scaffold fabrication technologies and their drawbacks. Section 2.3 reviews 
the RP technology. Section 2.4 examines some popular RP techniques that are used 
for TE scaffold manufacturing. Section 2.5 provides general observations based upon 
the literature reviewed.  
2.1 Scaffolds in Tissue Engineering 
In scaffold-based tissue engineering strategies, the scaffolds, built from 
synthetic or natural materials, serve as temporary surrogates for the native extra 
cellular matrix. The challenge in scaffold-based TE is to construct biologic replicas 
in-vitro such that the engineered composite becomes integrated for transplant in-vivo 
for the recovery of lost or malfunctioned tissues or organ. Subsequently, the 
composite should work coordinately with the rest of the body without risk of rejection 
or complications [Bell, 2000; Martins-Green, 2000]. 
2.1.1 Two-dimensional Scaffolds in Tissue Engineering 
Two-dimensional matrices, in the form of thin films, have special applications 
in tissue engineering.  
The earliest and most successful application of 2D matrices in tissue 
engineering is the regeneration of skin. As a result of the work done in this area for 
the past two decades, skin regeneration has now become a clinical reality [Cairns et al. 
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1993; Rastrelli, 1994; Kirsner et al., 1998; Philips, 1998; Teumer et al., 1998]. 
Bioresorbable polymers in the poly (α-hydroxy esters) family remain the most 
popular material choice for the fabrication of thin films for tissue engineering 
applications. For example, poly (lactic-co-glycolic acid) films of thickness 12-133µm 
have been fabricated using a modified solvent-casting method and shown to support 
the attachment of human retinal pigment epithelium cells in vitro [Thomson et al., 
1996]. Cell proliferation rates on the films were shown to be higher than that on tissue 
culture polystyrene controls [Lu et al., 1998]. A film of poly (ε-caprolactone) and 
poly(lactic acid) in a weight ratio of 1:1 and reinforced with woven poly(glycolic acid) 
has also been developed, made into a tube and used as a matrix for vascular 
endothelial cells [Burg et al., 1999; Shin'oka et al., 2001].  Recently, 2D films made 
of synthetic polymers have also been used as potential substrates for developing an 
artificial salivary gland [Aframian et al., 2000], because native salivary epithelial 
exists as a single layer.  
To date, 2D matrices have been applied in the regeneration of such tissues as 
vascular vessels, retinal epithelium and salivary gland, although the success rate is not 
as good as in skin. 
2.1.2 Three-dimensional Bioresorbable Scaffolds in Tissue Engineering 
The demand for transplant organs and tissues far outpaces the supply, and this 
gap will continue to widen [Cohen et al., 1993]. Cell transplantation was proposed as 
an alternative treatment to whole organ transplantation for malfunctioning organs 
[Cima et al., 1991]. For the creation of an autologous implant, donor tissue is 
harvested and dissociated into individual cells. The cells are then attached and 
cultured onto a proper substrate that is ultimately implanted back at the desired site of 
Chapter 2 Literature Review 
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the functioning tissue. However, it is believed that isolated cells cannot form new 
tissues by themselves. Most primary organ cells require specific environments that 
very often include the presence of a supporting material to act as a template for 
growth. The currently existing substrates are mainly in the form of 3D tissue 
engineering scaffold.  
 
2.2 Three-dimensional Scaffold Fabrication Techniques  
Conventional scaffold fabrication techniques include fiber bonding [Brauker et 
al.1995, Wang et al., 1993], phase separation [Lo, 1996, Ma and Zhang, 1999], 
solvent casting/particulate leaching [Mikos et al., 1993, Mooney et al., 1992, Holy et 
al., 2000, Mikos et al, 1994], membrane lamination [Mikos et al, 1996], melt molding 
[Thomson et al., 1995], gas foaming/high pressure processing [Baldwin et al., 1995, 
Mooney et al., 1996], hydrocarbon templating [Shastri et al., 2000], freeze drying 
[Whang et al., 1995, Healy et al., 1998] and combinations of these techniques (e.g., 
gas foaming/particulate leaching [Harris et al., 1998], etc.). The principles, procedures 
and applications or potential applications of these techniques can be found in several 
research works in literature [Vacanti et al., 1998, Lu and Mikos, 1996, Thomson et al., 
2000, Widmer and Mikos, 1998, Yang et al., 2001]. Although conventionally 
produced scaffolds have been applied to engineer a variety of tissues with varying 
success, most of the conventional techniques are limited by some flaws, which restrict 
their scope of applications. Among the main limitations are [Leong et al., 2002]: 
1) Manual intervention: All conventional techniques rely on manual processes 
that are labor-intensive and time-consuming. Most require multi-stage processing of 
the scaffold materials in order to form the desired scaffolds with the appropriate 
characteristics. The heavy reliance on user’s skills and experiences often results in 
Chapter 2 Literature Review 
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inconsistent outcomes and poor repeatability.  
2) Inconsistent and inflexible processing procedures: These result in highly 
inconsistent macro- and micro-structural and material properties that may be adverse 
to tissue regeneration. Many conventional techniques (e.g., solvent casting, freeze 
drying, phase separation, etc.) are sensitive to minor variation and as such, may 
produce results that differ between applications. Hence, the fabricated scaffolds 
usually possess inconsistent pore sizes, pore morphologies, porosities and internal 
surface areas over their entire volumes. 
3) Use of toxic organic solvents: Most conventional techniques involve extensive 
use of toxic organic solvents on the scaffold materials in order to convert the raw 
stock (granules, pellets or powders) into the final scaffold. Incomplete removal of 
solvents from the fabricated scaffolds, especially in thicker constructs, will result in 
harmful residues that have adverse effects on adherent cells, incorporated biological 
active agents or nearby tissues [Healy et al., 1998].  
4) Use of porogens: Salts or waxes are employed as porogens in some 
conventional techniques (e.g., particulate leaching, hydrocarbon templating, etc.) to 
create porous scaffolds. The use of porogens limits the scaffolds to thin membranes 
with thickness of 2mm [Lu and Mikos, 1996] to facilitate complete porogen removal. 
Porogen particles entrapped by the matrix will remain within the scaffold. Also, it is 
difficult to prevent the agglomeration of porogen particles and achieve uniform 
porogen dispersion. These factors will result in uneven pore densities and 
morphologies that have detrimental impact on the material characteristics of the 
scaffold. 
5)  Shape limitations: Molds or containers are used in some techniques to cast 
Chapter 2 Literature Review 
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scaffolds in thin membrane forms or simple uniform geometries. The melt molding 
technique, although capable of producing three-dimensional scaffolds, is limited by 
the complexity in the design and construction of the mold. Although techniques such 
as membrane lamination can create irregularly shaped scaffolds, the process is tedious 
and time-consuming due to the lamination of thin membrane layers. It may also result 
in limited interconnected pore networks. Table 2.1 summarizes the advantages and 
limitations of these conventional techniques [Leong et al., 2002]. 
Table2.1 Conventional polymer scaffold processing techniques for tissue engineering  
Process Advantages Disadvantages 
Fiber bonding Easy process 
High porosity 
High surface area to 
volume ratio 
 
High processing temperature for 
non-amorphous polymer 
Limit range of polymers 
Limit range of polymers 
Lack of mechanical strength 
Problems with residual solvent 
Lack of control over micro-
architecture 
Phase separation Allows incorporation of 
bioactive agents 
Highly porous structures 
Lack of control over micro-
architecture 
Problems with residual solvent 
Limited range of pore sizes 
Solvent casting and 
particulate leaching 
Highly porous structures 
Large range of pore sizes 
Independent control of 
porosity and pore size 
Crystallinity can be 
tailored 
 
Limited membrane thickness 
Lack of mechanical strength 
Problems with residual solvent 
Residual porogens 
 
Membrane lamination Macro shape control  
Independent control of 
porosity and pore size 
Lack of mechanical strength 
Problems with residual solvent 
Tedious and time-consuming 
Limited interconnected pores 
Melt molding Independent control of 
porosity and pore size  
Macro shape control  
 
High processing temperature for 
nonamorphous polymer 
Residual porogens 






Independent control of 
porosity and pore size 




Organic solvent free  
Allows incorporation of 
bioactive agents 
Nonporous external surface 





Organic solvent free  
Allows incorporation of 
bioactive agents 
Highly porous structures 
 Large range of pore sizes 
Independent control of 
porosity and pore size 
Limited interconnected pores 
 
Lack of mechanical strength 
Residual porogens 
 
Freeze drying Highly porous structures  
High pore 
interconnectivity 




No thickness limitation  
Independent control of 
porosity and pore size 




2.3 Rapid Prototyping  
Rapid Prototyping (RP) is the name given to a family of processes that are 
used to fabricate objects directly from a 3D computer model. The model is produced 
either by computer-aided design (CAD), 3D scanning or 3D reconstruction of 2D 
images. Such technologies are also known as Free-Form Fabrication (FFF), Solid 
Freeform Fabrication (SFF) or Layered Manufacturing (LM). Rapid prototyping is a 
relatively new technology, yet tremendous progress has been made in terms of the 
systems and materials in the last decade. 
The underlying concept of RP is the generation of a 3D physical model in a 
layer-by-layer manner through a process that deposits, bonds or fuses material onto 
the previous layer under computer control [Lamont, 1993]. It is notable that RP uses 
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an "additive" fabrication process, fabricating 3D models by "building-up" rather than 
"cutting-away" processes, compared with the conventional manufacturing methods 
such as forming or material removal, etc.  
In RP process, 3D objects are decomposed into 2D layers, and planning on 2D 
domain is relatively simple. The planning of the fabrication is largely automatic, 
demanding little human intervention and robust process planning is easier to 
implement. RP is especially suitable in areas such as mold production in injection 
molding industries [Wohlers, 1999], where the high cost is offset by the huge 
reduction in fabrication time and the flexibility for customized jobs. RP also allows 
the special capability of fabricating enclosed cavities, something which precision 
CNC, arguably the closest rival to RP in terms of speed and versatility, cannot achieve. 
The rapid prototyping technology enables quick and easy transition from 
concept generation in the form of computer images to the fabrication of physical 
models. It is an effective technology to expedite the product development.  
Traditionally, designers required CAD part design, tooling design, tool path 
programming and tooling machining and molding to test CAD designs, which is a 
long cycle in the order of months, even years and high cost. RP is of special interest in 
the non-repetitive fabrication of models with great complexity without high cost. RP 
technology is now emerging as a major link between part design and manufacturing. 
In general, the attributes of RP can be summarized as: (1) a material additive 
process; (2) ability to build complex 3D geometries, including enclosed cavities; (3) 
process is automatic and based on a CAD model; (4) requires little or no part-specific 
tooling or fixturing; (5) requires minimal or no human intervention to operate. 
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2.3.1 Popular RP Technologies 
There are six well-known RP technologies available in the market and these are 
stereolithography (SL), fused deposition modeling (FDM), solid ground curing (SGC), 
laminated object manufacturing (LOM), selective laser sintering (SLS), and 3D 
printing (3DP).  
1) Stereolithography (SL) [Lu et al., 2001]: Stereolithography, which is a 
combination of computer graphics, laser technology and photochemistry, creates 3D 
parts by selectively solidifying polymeric materials layer-by-layer upon exposure to 
ultra-violet radiation or laser beams. It is currently the most accurate RP process in 
terms of dimensional accuracy and capability in creating small fine features.  
However, prototype parts created by currently available SL systems exhibit weak 
mechanical properties and significant amount of shrinkage.  
2) Fused Deposition Modeling (FDM) [Kochan, 1997; Hutmacher, 2000]: An 
FDM machine consists of a movable head which deposits a thread of molten material 
onto a substrate.  After a layer is completed, the platform on which the material is 
extruded is lowered by one layer thickness, and the extrusion process repeats. FDM 
employs the concept of melt extrusion to deposit a parallel series of material roads 
that forms a material layer. In FDM, filament material stock (generally thermoplastics) 
is fed and melted inside a heated head before being extruded through a nozzle with a 
small orifice. The material is deposited in very thin layers and bonds onto the 
previous when the material solidifies. After a layer is completed, the table is lowered 
by one layer thickness, and the extrusion process begins again.  
3) Solid Ground Curing (SGC) [Kochan, 1993]: This system utilizes photo-
polymer resins and ultra-violet (UV) light.  Data from the CAD model is used to 
Chapter 2 Literature Review 
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produce a mask which is placed above the resin surface.  When the layer has been 
cured, the excess resin is wiped away and spaces are filled with wax.  The wax is 
cooled and the wax chips removed.  A new layer of resin is applied and the process is 
repeated. The advantages of SGC are that the entire layer is solidified at once; 
reducing the part creation time, especially for multi-part builds.  Also, no post-curing 
is required. The disadvantages of this system are that it is noisy, large and needs to be 
constantly manned.  It wastes a large amount of wax which cannot be recycled and is 
also prone to breakdowns. 
4) Laminated Object Manufacturing (LOM) [Cooper, 2001]: The build material 
is applied to the part from a roll, and then bonded to the previous layers using a hot 
roller which activates a heat sensitive adhesive.  The contour of each layer is cut with 
a laser that is carefully modulated to penetrate to the exact depth of one layer.  After 
the layer has been completed and the build platform lowered, the process repeats itself. 
However, there is a need to separate the finished parts from the build platform, which 
affects their surface finish, creating a large amount of scrap.  There is also a need to 
hand polish the finished parts. 
5) Selective Laser Sintering (SLS) [Lu et al., 2001]: In the SLS process, a layer 
of powder is deposited on a support and leveled by a rolling device.  A laser beam 
then scans and sinters a 2D pattern on the deposited powder layer.  After sintering a 
layer, a new layer of powder is deposited in the same manner.  By successive powder 
deposition and laser scanning, a 3D part is built. 
6) 3D Printing (3DP) [Stephen et al., 1998]: Developed at the Massachusetts 
Institute of Technology (MIT), this technology is based on the bubble jet printing of a 
binder, much like a conventional desktop printer. In fact, some commercial models of 
3DP machines utilize the same print cartridge packages as commercial printers. 
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Instead of printing on paper, a print head prints onto a bed of powdered material 
following the object’s profile as generated by the system computer.  The binder is 
delivered to the powder bed to produce the first layer and the bed is then lowered by a 
fixed distance. Powder is then deposited and spread evenly across the bed with a 
roller mechanism, and a second layer is built. This is repeated until the entire model is 
fabricated. The completed object is embedded inside unprocessed powders and is 
extracted by brushing away the loose powders. The process can produce porous parts 
but lack strength without post fabrication processing 
2.3.2 RP Materials 
There is a wide choice of materials for RP processing, which can be generally 
classified into these few categories: 
1) Reactive liquids that change into solids with application of radiation 
(photopolymers), e.g. stereolithography (SL);  
2) Powder bonding, directly or with a binder, e.g. selective laser sintering (SLS), 
3D printing (3DP); 
3) Plastic or wax extruded under heat or in pre-cured form, e.g. fused deposition 
modelling (FDM), 3D plotting; 
4) Laminates cut to shape and stacked together, e.g. laminated object 
manufacturing (LOM). 
A wide range of materials can fit into these categories; hence increase the 
flexibility and applicability of the various RP processes in different areas. Among 
these, the powder bonding and polymer extrusion processes have the widest 
applications, especially in the biomedical field [Rüdiger Landers & Rolf Mülhaupt, 
2000]. 
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2.4 Scaffold Building Using RP Technologies 
With the advent of cell and tissue culture technologies and the long-term 
biocompatibility advantages of such implants over non-biological materials, the drive 
is towards culturing matching cell types within biodegradable scaffolds. The speed 
and customizability of RP enable construction of individual, patient-specific scaffolds, 
and the capability of internal cavities allows specially designed internal structures. 
The inherent porosity of many RP processes, such as 3DP and FDM, is critical here 
for the successful establishment of the cells into the structure. 
Some significant advantages derivable with scaffold fabrication using RP 
technology include: 
1) Customized design: Direct utilization of CAD models as inputs for scaffold 
fabrication allows complex scaffold designs to be realized. Patient-specific data and 
scaffold structural properties required for regenerating specific tissues can be 
incorporated into the scaffold design via CAD. 
2) Computer-controlled fabrication: The use of automated computerized 
fabrication will result in high throughput production with minimal manpower 
requirements. The high build resolution of RP technologies coupled with the ability to 
define and control individual process parameters will enable the creation of highly 
accurate and consistent pore morphologies. Using CAD and RP technologies, 
scaffolds with porosities exceeding 90% and complete pore interconnectivity can be 
realized. The ability to optimize scaffold designs will facilitate cell attachment, 
colonization and proper ECM (extra cell matrix) formation. 
3) Anisotrophic scaffold microstructures: The use of CAD and RP will allow 
user to control the localized pore morphologies and porosities to suit the requirements 
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of different cell types within the same scaffold volume. This is achieved by 
incorporating different controllable macroscopic and microscopic design features on 
different regions of the same scaffold. Having an anisotrophic scaffold microstructure 
is advantageous in TE applications where multiple cell types arranged in hierarchical 
structures are necessary [Park et al., 1998, Hutmacher et al., 2001]. 
4) Processing conditions: RP techniques employ a diverse range of processing 
conditions that include solvent and porogen-free processes and room temperature 
processing. Some RP techniques allow pharmaceutical and biological agents to be 
incorporated into the scaffolds during fabrication [Leong et al., 2001, Low et al., 2001, 
Wu et al., 1996]. 
At present, several RP techniques have been exploited for scaffold fabrication, 
which include: 
1)  Three-dimensional printing (3DP) 
The versatility and simplicity of 3DP allow the processing of a wide variety of 
powder materials including polymers, metals and ceramics. So far, 3DP is perhaps the 
most widely investigated RP technique for scaffold fabrication.  
Kim et al. [1998] employed 3DP with particulate leaching technique for 
creating porous scaffolds using polylactide-coglycolide (PLGA) powder mixed with 
salt particles and a suitable organic solvent. Cylindrical scaffolds measuring 8mm 
(diameter) by 7mm (height) were fabricated. The salt particles were leached using 
distilled water after 3DP fabrication to result in scaffolds with pore sizes of 45–150 
mm and 60% porosity. To improve pore interconnectivity and porosity, the scaffolds 
were constructed by printing and horizontally stacking 800 mm diameter longitudinal 
channels that were arranged in parallel throughout the scaffolds’ height. 
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Zeltinger et al. [2001] employed 3DP fabricated porous poly (l-lactic acid) (l-
PLA) disc shaped scaffolds measuring 10mm (diameter) by 2mm (height) to 
investigate the influence of pore size and porosity on cell adhesion, proliferation and 
matrix deposition. The scaffolds were constructed with two different porosities (75% 
and 90%) and four different pore size distributions (>38, 38–63, 63–106 and 106–150 
mm) that were formed using salt and leaching methods. 
Lam et al. [2002] developed a blend of starch-based powder containing 
cornstarch (50%), dextran (30%) and gelatin (20%) that can be bound by printing 
distilled water. Cylindrical scaffolds measuring 12.5mm (diameter) by 12.5mm 
(height) were printed and characterized. Both solid cylindrical scaffolds as well as 
structures constructed by stacking cylindrical (2.5mm in diameter) or rectangular 
(2.5mm_2.5 mm) cross sectional channels were fabricated. 
Other research works that have exploited the capabilities of 3DP include the 
work of Park et al. [1998]. In their work, 3DP was employed with surface 
modification methods for creating scaffolds with controllable anisotrophic 
microstructures and surface chemistry. Stephen et al. [1998] have been able to 
illustrate that micro-porous 3D scaffold can be created using 3DP on copolymers of 
polylactide-coglycolide.  
The advantage of this process is the relatively fast speed and the ability to 
fabricate complex geometries with overhang due to the support of the powder bed. 
However, one disadvantage is that small pore size cannot be achieved with this 
technology.  
2) Fused deposition modeling (FDM) 
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Developed by Stratasys Inc. FDM process is one of the most successful RP 
systems in the market. It is gaining more and more market because of its ability to 
build parts with thermoplastic material, which is widely used and relatively cheap.  
 Zein et al. [2002] employed FDM for producing poly (e-caprolactone) (PCL) 
scaffolds with different geometrically consistent honeycomb-like patterns and fully 
interconnected porous channels. The scaffolds were constructed with pore/channel 
sizes ranging from 160 to 700 mm and 48% to 77% porosities. The different 
honeycomb designs were obtained by employing different laydown patterns for each 
consecutively deposited layer. Different channel sizes were obtained by varying the 
spacing between the extruded roads of polymeric material. 
 Hutmacher et al. [2001] investigated the in-vitro cell cultural response of 
primary human fibroblast and osteoblast cells on FDM-fabricated PCL scaffolds. 
Rectangular scaffolds measuring 32mm (length) by 25.5mm (width) by 13.5mm 
(height) and comprising of two different microstructures formed using two different 
laydown patterns (i.e., (1) 0_/60_/120_ and (2) 0_/72_/144_/36_/108_) were 
fabricated. The scaffold porosities were measured to be 61%. Both microstructures 
exhibited complete pore interconnectivity. 
 Bose et al. [1998] and Hattiangadi et al. [1999] applied an indirect fabrication 
method involving FDM for producing porous bioceramic implants. In their research, 
FDM was employed to fabricate wax molds containing the negative profiles of the 
desired scaffold microstructure. Ceramic scaffolds were then cast from the molds via 
a mold technique. Ceramic scaffolds with 31–55% porosities, pore sizes of 150–750 
mm and complete pore interconnectivity were produced. 
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Other FDM-based researches conducted include the work carried out by 
Leong et al., [2002]. In their work, FDM filaments made from different grades of high 
density polyethylene (HDPE) were processed on a FDM1650 system (Stratasys Inc.).  
By changing the direction of material deposition for consecutively deposited 
layers and the spacing between the material roads, scaffolds with highly uniform 
internal honeycomb-like structures, controllable pore morphology and complete pore 
interconnectivity are obtained. In order to fabricate scaffold designs with overhanging 
features, removable supporting structures are deposited alongside the scaffold to 
support such features. However, the main disadvantage of this process is the 
restriction on thermoplastic materials. The high temperature required to melt the 
material rule out the possibility of using any heat sensitive materials as base material 
or as additives.     
3) Selective laser sintering (SLS) 
SLS employs a CO2 laser beam to selectively sinter polymer or composite 
(polymer/ceramic, multiphase metal) powders to form material layers. The laser beam 
is directed onto the powder bed by a high-precision laser scanning system. The fusion 
of material layers that are stacked on top of one another replicates the object’s height. 
During fabrication, the object is supported and embedded by the surrounding 
unprocessed powders and has to be extracted from the powder bed after fabrication. 
Since the powders are subjected to low compaction forces during their deposition to 
form new layers, SLS-fabricated objects are usually porous. The porosity of SLS-
fabricated objects can be controlled by adjusting the SLS process parameters [Leong 
et al., 2001, Low et al., 2001]. 
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Lee and Barlow [1994, 1993] prepared various forms of calcium phosphate 
powders with Ca/P ratios ranging from 0.5 to 1 by reacting hydroxyapatite (Ca5
(OH)(PO4)3) with  phosphoric acid. The pore sizes of the SLS-fabricated ceramic 
parts were reported to measure around 50 mm and were well interconnected. 
Problems encountered were mainly due to shrinkage of the parts during sintering. 
4) Three-dimensional plotting (3D-Plotting)  
In these types of systems, a dispenser head is controlled by a 3-axis platform, 
typically a CNC machine or robot. The process generates an object by building micro 
strands or dots in a layered fashion. Depending on the type of dispenser head, a 
variety of materials can be used to build scaffolds. 
The advantage of such a system is its versatility with a wide range of fluids 
and the absence of hot processes, often adverse for biological materials. This method 
is generally low cost with minimal specialized equipment required. A simple 
adaptation of dispenser heads will allow a wide variety of thermoplastic polymers as 
well as practically any pastes and solutions.  
Landers et al. [2000] presented a new technique that can make use of a wide 
variety of polymer hot melts as well as pastes, solutions and dispersions of polymers 
and reactive oligomers. However, resolution is the primary limiting factor, determined 
by the size of dispensing tip. Vozzi et al. [2001] achieved resolution as low as 10µm 
through the use of microsyringes and electronically regulated air pressure valves.   
A microsyringe-based 3D scaffolds fabrication technique was also described 
by Vozzi et al [2002].  It employs a highly accurate three-dimensional 
micropositioning system with a pressure-controlled syringe to deposit biopolymer 
structures with a lateral resolution of 5 mm. The pressure-activated microsyringe is 
Chapter 2 Literature Review 
 23
equipped with a fine-bore exit needle, through which tiny amounts of polymer ooze 
out when pressure is applied to the syringe. A wide variety of two- and three-
dimensional patterns can be fabricated. Poly-L-lactic acid (PLLA), polycaprolactone 
(PCL) and blend of PLLA and PCL were used in their research. Experiments 
indicated the simplicity and possibility of scaffold fabrication with various 
biopolymers. 
5) Laminated object manufacturing (LOM) 
LOM is a process where individual layers are cut from a sheet by a computer-
controlled laser, after which the individual layers are bonded together to form a 3D 
object. LOM has been used for fabrication of bioactive bone implants, using HA and 
calcium phosphate laminates [Steidle et al., 1999].  A HA/glass tape is laid down on 
the working platform. The outside profile of the layer to be built is cut using a laser 
directed by an XY plotter. The laser only cuts to the depth of a single layer. A second 
layer of the HA/glass tape is laid down on top of the first and a heated roller passes 
over the two squeezing and bonding them together. The entire object is formed in this 
way.  
The downside in this process is the burnt edges due to the laser cut, not an 
issue with most applications, but creates unwanted and possibly harmful debris in 
biomedical applications. Material degradation in the heated zone may also occur.  
6) Multiphase Jet Solidification (MJS) 
The basic principle of MJS is to extrude melted material through a jet, similar 
to FDM. In contrast to FDM, the MJS process is mainly designed to produce high-
density metallic and ceramic parts.  
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In Koch and coworker’s research [1998], the MJS technology was used to 
create bio-compatible implants. The material used in this research is a biocompatible 
and bioresorbable poly-lactide material instead of the usual powder-binder-mixture of 
stainless steel. Table 2.2 summaries the advantages and disadvantages of different RP 
technologies. 
Table 2.2 Comparison of different RP technologies 
RP 
Technique 
Materials Advantage Disadvantage 
3D printing  Ink+powder of bulk 
polymers, ceramics 
No inherent toxic 
components  
Fast processing  
Low costs 
Weak bonding between 
powder particles  
Bad accuracy-rough 
surface 
FDM/FDC Some thermoplastic 
polymers/ceramics 
Low costs  
 
Elevated temperatures 
Small range of bulk 
materials  
Medium accuracy 





Broad range of 
materials  
Broad range of 
conditions 
Incorporation of 
cells proteins and 
fillers  
Slow processing  
Low accuracy  
No standard condition-
time consuming 











range of bulk 
materials 
Materials trapped in small 
inner holes is difficult to 
be removed, 
biodegradable materials 






Relative easy to 
remove support 
materials, 
Relative easy to 
achieve small 
feature 
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Noisy, large and needs to 
be constantly manned. 
Wasting a large amount of 
wax which cannot be 
recycled. 
Prone to breakdowns. 






can be made 
quite large. 
Need to separate and hand 
polish the finished parts 
from the build platform  
Material degradation in 
the heated zone may also 
occur. 
MJS Stainless steel, 








Shrinkage occurs during 
sintering 
 
2.5  Observations 
The literature has shown that much research effort has been put to the TE 
scaffold fabrication and application. In general, Rapid prototyping (RP) is suitable for 
tailoring individual patient-specific scaffold parts because of its flexibility to build 
complex structures. Though studies have shown these RP techniques have the 
potential to produce biomedical scaffolds, each has its shortcomings. 3DP requires 
post processing to improve the mechanical properties of the scaffold. FDM, on the 
other hand, allows the application of only thermoplastic polymers. This prevents the 
implementation and application of biological agents and natural polymers as 
temperature induces protein inactivation. Additionally, the major proportion of the 
scaffold fabrication supported by RP technology was based upon melt and powder 
processing. Future research in customized scaffold fabrication concerns greater 
flexibility and low cost for clinical reality. 
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Chapter 3  
Materials and Methods 
 
The selection of materials plays a key role in the design and development of 
scaffolds suitable for tissue engineering [Vacanti et al., 1994].  Ideally, the material 
used for TE scaffolds should meet the following design criteria [Freed et al., 1994]: 
1) Surface property: During the implantation of the cells in-vitro, the scaffold is 
soaked in a suspension of cells. The surface should promote proper attachment and 
growth of the cells onto the structure. Often, additives such as hydroxyapatite (HA) 
are added to the basic scaffold material to promote cell attachment on biomedical 
scaffolds.  
2) Material degradation: A scaffold should fully degrade once it has served its 
purpose of providing a template for the regenerating tissue. The material needs to be 
reabsorbed by the tissue after the cells have established themselves; hence its 
degradation products should not provoke acute inflammation or toxicity when 
implanted in-vivo and a controllable degradation rate is critical to ensure that proper 
cell growth is achieved before absorption. 
3) Material processable ability: Material should be reproducibly processable into 
a variety of shapes and sizes. 
4) Mechanical properties: Lastly, the area and type of implant will require 
scaffold material of suitable mechanical properties, e.g. more rigid PCL scaffolds 
favor applications in bone cell cultures while soft chitosan scaffolds are more suitable 
for soft tissues. 
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3.1 Materials Used for Tissue Engineering Scaffolds 
In literature there are basically two classifications of biomaterials used in the 
fabrication of scaffolds for tissue engineering. They are natural or biologically derived 
polymer and synthetic polymer.  
3.1.1 Natural Polymers 
The rationale behind the use of natural polymers as matrix materials is to 
mimic, as closely as possible, the natural environment of the extra cellular matrix 
(ECM) that forms the framework of all tissues in the body. Natural polymers, being 
very similar to macromolecular substances which the biological environment is 
capable of interacting with, may thereby minimize the problems of poor 
biocompatibility and stimulation of a chronic inflammatory reaction. Such positive 
cell-matrix interactions also introduce the possibility of designing matrices which 
function biologically at the molecular level. This means that besides providing a 
structural role, matrices could also play a part in enhancing tissue regeneration.  The 
natural polymers used as matrix materials thus include those that exist in natural ECM, 
such as collagen and various glycosaminoglycans and those that exist elsewhere in 
nature, such as chitosan. 
Collagen 
Collagen is a major constituent of all ECM in the human body, and is thus a 
natural choice as a matrix material. There are many types of collagen [Mayne and 
Burgeson, 1987], which are tissue-specific, and their primary role is to provide 
structural support. The shape and properties of each type of collage is dependent on 
the structure of the triple-helix of the molecule [Linsenmayer, 1991]. However, it has 
become clear now that collagens have also numerous developmental and 
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physiological functions. The pioneers of skin tissue engineering focused on natural 
bioresorbable collagen lattices as cell matrices. Bell et al. [1981a, 1981b, 1983] used 
collagen lattices to develop bilayered skin equivalents. Collagen has also been used in 
cartilage [Roche et al., 2001], bone [Du et al., 1999], muscle [van Wachem et al., 
1996] and liver [Ranucci et al., 2000] regeneration.  
Glycosaminoglycans (GAGs) 
The next group of natural polymers used is glycosaminoglycans (GAGs). 
GAGs are negatively charged and heavily hydrated linear polymers of repeating 
disaccharides that exist in the ECM, usually as part of proteoglycans. There are four 
classes of GAGs: hyaluronic acid (HA), chondroitin sulfate (CS), keratan sulfate (KS) 
and heparan sulfate (HS). To date, HA and CS are the most commonly used GAGs as 
matrix materials for tissue engineering. The attractiveness of using HA lies in its 
ability to promote cell proliferation, migration and define the space in which cells 
differentiate and form new matrices [Toole, 1991; Wight et al., 1991].  
Chitosan 
Another natural polymer, which has been commonly studied as a matrix 
material, but exists outside the human body in nature, is chitosan.  It has been 
extensively studied both as a drug delivery medium [Chellat et al., 2000] and as a cell 
carrier [Mori et al., 1997; Chuang et al., 1999].  
In brief, results from the use of natural biodegradable polymers as cell 
matrices have been encouraging. 
3.1.2 Synthetic Polymers 
The advantages of synthetic bioresorbable polymers over natural ones include 
better mechanical properties, more readily processable into a variety of shapes and 
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forms using various fabrication techniques [Thomson et al., 1997] and more easily 
modified degradation and resorption profiles. 
 Poly (α-hydroxy esters) 
Aliphatic polyesters in the family of poly (α-hydroxy esters), including poly 
(glycolic acid) (PGA), poly (lactic acid) (PLA), and their copolymers, have been most 
widely studied as matrix materials. These polymers were approved for in-vivo use by 
the Food and Drug Administration (FDA) and have been developed for use as various 
sutures, drug delivery systems and matrices for tissue regeneration [Park and Park, 
1994; Chu, 1995; Dunn, 1995; Athanasiou, 1996; Hutmacher et al., 1996].  
Poly (ε-caprolactone) 
 Poly (ε-caprolactone) (PCL) is a semi-crystalline aliphatic polyester which 
belongs to the family of poly (ω-hydroxy esters) [Kimura, 1993]. It is soluble in 
solvents such as chloroform and methyl chloride but only partially soluble in acetone 
and ethyl acetate.  
 A novel method of fabricating 3D porous scaffolds with PCL, via fused 
deposition modeling, was developed and studied as potential matrices for tissue 
engineering by Hutmacher[2000] and his coworkers [Hutmacher et al, 2001]. The 
scaffolds have been used in the studies of bone [Hutmacher et al., 2000a] and 
cartilage [Hutmacher et al., 2000b] regeneration. Promising results have been shown 
in terms of the scaffolds’ ability to support the attachment and proliferation of 
different cell types, and the formation of preliminary cartilage and bone-like tissue 
both in-vitro and in-vivo. 
Chapter 3 Materials and Methods 
 30
3.2 Protocol of Material Preparations  
3.2.1 Materials Used in the Research 
Among the commonly used biomaterials in TE, chitosan is a promising 
materials considering of its biocompatibility and abundant source. Besides the use as 
a drug delivery medium [Chellat et al., 2000] and as a cell carrier [Mori et al., 1997; 
Chuang et al., 1999], It has also been shown that chitosan has the potential to be 
fabricated into various porous structures, including membranes, blocks, tubes and 
beads [Madihally and Matthew, 1999]. Furthermore, chitosan contains hydroxyl and 
amine groups, and therefore has the potential to cross-link with other useful 
biomaterials, such as poly (vinyl alcohol) [Chuang et al., 1999] and rayon [Yunlin et 
al., 1998]. Chitosan cross-linked with collagen and polyvinyl pyrrolidone has been 
used as matrices in skin regeneration [Shahabeddin et al., 1990; Risbud et al., 2000]. 
Park et al. [2000] also showed that platelet-derived growth factor incorporated 
chitosan sponge has the ability to induce better attachment and higher proliferation 
rate of osteoblastic cells in-vitro. Lahiji et al. [2000] seeded human osteoblasts and 
chondrocytes on chitosan films cast onto plastic cover slips and showed that the films 
support the expression of collagen type I in the osteoblast cultures and collagen type 
II in the chondrocyte cultures. Various groups have shown that chitosan appears to be 
a suitable matrix material for tissue engineering applications.  
3.2.2 The Properties of Chitosan  
Chitosan is the product of the partial deacetylation of the naturally occurring 
polysaccharide chitin, which is found widely in nature as the skeletal material of 
crustaceans.  It has a chemical structure similar to chitin, but it is less produced in 
nature compared to chitin. Chitosan has been proposed as a biomaterial because it has 
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been shown to be non-toxic [Chandy and Sharma, 1990; Rao and Sharma, 1997], 
biodegradable [Hirano et al., 1989] and possesses good biocompatibility properties 
[Lee et al., 1995; Shigemasa and Minami, 1996]. 
       
Figure 3.1 Structure of chitosan 
Because of the stable, crystalline structure, chitosan is normally insoluble in 
aqueous solutions above pH 7. However, in dilute acids, the free amino groups are 
protonated and the molecule becomes fully soluble below pH 6.5. The pH-dependent 
solubility of chitosan provides a convenient mechanism for processing under mild 
conditions. Viscous solutions can be extruded and gelled in high pH solutions or baths 
of non-solvents such as methanol. Such gel fibers can be subsequently drawn and 
dried to form high-strength fibers [Hirano, 1996]. 
Structurally, chitosan is a linear polysaccharide. In general, these natural 
polymers have been found to evoke a minimal foreign body reaction. Formation of 
normal granulation tissue appears to be the typical course of healing and chronic 
inflammatory response does not develop. The effects of chitosan and chitosan 
fragments on immune cells may play a role in inducing local cell proliferation and 
ultimately integration of the implanted material with the host tissue. In vivo, chitosan 
is degraded by enzymatic hydrolysis. The degradation products are chitosan 
oligosaccharides of variable length. The degradation kinetics appears to be inversely 
related to the degree of crystallinity, which is controlled mainly by the degree of 
deacetylation [Shigemasa and Minami, 1996]. 
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One of chitosan’s most promising features is its excellent ability to be 
processed into porous structures for use in cell transplantation and tissue regeneration. 
Freezing and lyophilizing chitosan acetic acid solutions can form porous chitosan 
structures. A number of researchers have studied chitosan-based scaffolds in various 
tissue engineering applications [Onishi and Machida, 1999; Eser et al., 1998; Elcin et 
al., 1999; Madihally and Matthew, 1999; Sechriest et al., 2000; Janeen and Angela, 
2000]. 
For future applications it is important that the chitosan-scaffold meet 
mechanical properties to withstand in vitro and in vivo forces in order to provide 
seeded cells with a proper biomechanical environment. Hence, the scaffold should be 
able to withstand the contraction forces of blood clot, tissue reaction and finally tissue 
formation as well as remodeling. For example, development of chitosan-based matrix 
that can support chondrogenesis may be significant not only in terms of the quality of 
tissue produced, but also in terms of the ability of that tissue to integrate with the host 
matrix. 
3.2.3 The Protocol of Chitosan Gel Preparation 
In this research, chitosan was used as the scaffold material. High-purity and 
high-viscosity chitosan with a deacetylation degree of more than 80% was obtained 
from CarboMer, Inc, Washington, USA. Sodium Hydroxide Pellets were obtained 
from J.T. Baker, Phillipsburg, NJ, USA.  
 Chitosan is insoluble in water due to its stable crystalline structure and has to 
be prepared by dissolving the chitosan powder in acetic acid. All chitosan powder is 
soluble at pH lower than 6.5 to form viscous solutions [Tachibana et al., 1988]. The 
percentage of acetic acid used for dissolution ranged from 1.2% (v/v) to 5% (v/v) in 
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water. In this research, tests done showed that 2%v/v acetic acid was high enough to 
dissolve the chitosan powder completely to form transparent chitosan gel, so 2% (v/v) 
was used in this case. 
 The chitosan gel was prepared by dissolving 3%w/v chitosan in 2%v/v acetic 
acid. The mixture was magnetically stirred for 2 hours at room temperature in a 
beaker, the mouth of which was covered with a film during stirring. The reason for 
covering the beaker was to prevent evaporation during stirring, which would change 
the material concentration. The chitosan gel was then filtered and placed into a 
vacuum oven for half an hour to remove air bubbles introduced into the gel during 
stirring. This step is of utmost importance as the viscous gel must be completely 
bubble-free for consistent extrusion.  
3.2.4 Preparation of Sodium Hydroxide Solution   
The NaOH solution was prepared by 8%v/v NaOH and 100% high-grade 
ethanol mixed in a ratio of 7:3 in this study. These solutions were prepared fresh just 
before fabricating the scaffolds.  
3.3  Scaffold Fabrication  
A micro-syringing robotic system (RPBOD) with multiple-dispensr head built 
in-house was used for this project. The prepared chitosan gel was contained in one of 
the plastic syringe barrel and dispensed by pressurized purified air. Purified air was 
used for this purpose to ensure a clean environment. NaOH solution was used as 
coagulation and dispensed via another syringe using a motorized plunger. 
To fabricate a scaffold, the chitosan and NaOH are sequentially dispensed in 
each strand pass. The chitosan fluid is extruded and allowed to contact the base. The 
coagulation medium (NaOH) followed closely after the chitosan spread out. The two 
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materials react to precipitate into a strand. As shown in Figure 3.2, the tip on the right 
dispenses the chitosan and that on the left dispenses the NaOH solution, positioned 
approximately 5 mm apart. The dispense sequence is from left to right, and the 
nozzles are individually timed to dispense only when over the same section. In the 
dispensing process, the chitosan gel is dispensed as the dispenser moves (from left to 
right), leaving the chitosan gel on the base.  Immediately following, the mechanical 





Figure 3.2 Dual dispensing method 
 
After the first layer, the base is rotated by 90 degrees and the dispensers are 
lifted to a higher level that allows for the chitosan gel for the next layer to lie on the 
previous layer. The robot then generates the second layer and the scaffold is 
progressively built as layers are sequentially generated in this manner. 
3.4 Washing Protocol 
Once the scaffold was made, it was rinsed three times with distilled water and 
left in 100%, 70% ethanol sequentially for 30mins each and subsequently washed 
three times with distilled water. Finally, the scaffold was left in deionized water in the 
refrigerator overnight. This was a precautionary step to leach out any residual NaOH 
solution. The excess water was drained and the scaffold was left in the oven at 400C 
for 2 hours. This step was taken because previous experiments indicated that the 
ChitosanNaOH
Chitosan tip clears the 
surface by 0.1~0.2mm 
NaOH tip clears the 
strand by 0.1~0.2mm 
Motion 
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material properties of the scaffolds were improved by heating before freeze-drying 
[Sultana, 2002].  The washed scaffold was then transferred to a freezer and frozen for 
at least 8 hours. After that, the frozen scaffold was transferred to a freeze-drier and 
dried for 2 days.  
3.5 Scaffold Characterization 
Besides material issues, the macro- and micro-structural properties of the 
scaffold are also very important [Cima et al., 1991; Wake et al., 1994]. In general, the 
scaffolds require individual external shape and well defined internal structure with 
interconnected porosity. 
Ideally, a scaffold should have the following characteristics: [Thomson et al, 
1995; Hutmacher, 2001] 
(1)  be highly porous with an interconnected pore network for cell growth and 
flow transport of nutrients and metabolic waste;  
(2) have suitable surface chemistry for cell attachment, proliferation, and 
differentiation; 
(3) possess mechanical properties to match those of the tissues at the site of 
implantation;  
(d)  be easily fabricated into a variety of shapes and sizes and  
(e) possess interconnecting porosity so as to favor tissue integration and 
vascularity. 
3.5.1 Porosity 
The pore structure is a very important parameter of the scaffold structure 
because it determines permeability, mechanical properties and cell growth. The ratio 
of scaffold apparent volume (V), which means the volume of the whole scaffold 
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including the inside pores, to scaffold true volume(V’), which means the volume of 
the scaffold materials was used to calculate the porosity (ε). The porosity was 
calculated by the following method [Hutmacher et al., 2000]:  
(1) Measuring the weight (m) and apparent volume (V) of each sample. 
(2) Calculating from these measurements, the apparent density of the scaffolds 
                          ρ* = m / V                                                                            (3.1) 
(3) Using the formula 
                          ε= 1 - ρ*/ρ × 100%.                                                             (3.2) 
The protocol used for calculating the apparent and true density of scaffold was 
proposed by Zhang et al. [2001]. To obtain the volume of the scaffold, a sample of 
weight W was immersed in a graduated cylinder containing a known volume, V1, of 
ethanol. In this method ethanol was used as the displacement liquid because it 
penetrated easily into the pores and did not induce swelling or shrinkage [Xiong et al., 
2001].  The scaffold sample was kept in the ethanol for 5 minutes. Then the graduated 
cylinder was put into vacuum oven for half an hour and then taken out. These 
evacuation and re-pressurization cycles were continued until no air bubbles emerged 
from the scaffolds and this volume was taken as V2. The volume difference (V2-V1) 
was taken as the true volume of the scaffold (V’), which is the volume of the scaffold 
material. The soaked scaffold was then removed and the residual ethanol volume was 
recorded as V3. Because the ethanol had entered into the pores of scaffold and was 
removed with the scaffold, the volume difference (V1-V3) can be considered as the 
volume of the pores of scaffold.  Then the scaffold apparent volume (V), which means 
the volume of the whole scaffold including the inside pores, can be calculated by (V2-
V1) plus (V1-V3), as shown by equation (3.3). The true density (ρ) and apparent 
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density (ρ*) were calculated using equations (3.4) and (3.5), respectively. Porosity of 
the scaffolds was calculated using equation (3.6). 
Apparent Volume,             V= (V2 - V1) + (V1 – V3) = V2 – V3              (3.3) 
True Density,                     ρ = W / V’ = W/ (V2 –V1)                                (3.4) 
Apparent Density,              ρ* = W/ V =W / (V2-V3)                                  (3.5) 
Porosity,         ε =1 - ρ*/ρ× 100%   = (V1 –V3) / (V2 – V3) × 100%          (3.6) 
3.5.2 Morphology 
SEM (scanning electron microscope) is a popular technique used in the 
analysis of surface topography of materials and the interaction between the substrate 
and cells. Specimens to be viewed with SEM need to be dried and fixed.  
The freeze-dried chitosan scaffolds were mounted on an aluminium specimen 
holder with double sided carbon tape and observed under a Jeol JSM-5800LV (JEOL 
USA, Peabody, MA) environmental scanning electron microscope (ESEM) at 15V to 
assess the gross morphology and microstructures.  
3.5.3 Mechanical property  
Compression tests were conducted with an Instron Microtester material testing 
system (Instron, MA, USA) using a 10N load cell to find out the load bearing capacity 
of the scaffolds. The compressive modulus and failure point were evaluated from the 
stress–strain graph. A sample set of three scaffolds, which were cut into 8x8x3 mm 
cuboids, was used for the compression test. The test was conducted four times using 
different sample sets and the average value was calculated. 
 
 









A typical stress-strain curve for a biological material is shown in Figure 3.4 
[Mow. et al., 1997]. Ei stands for the Initial Compressive Modulus, while Ef stands 
for the Final Compressive Modulus. Ei and Ef can be obtained from the stress-strain 
curve by calculating the slops of the two tangents of the curve at the initial and final 
point, ε-f is the intersection point of the tangents. Since the scaffolds have the 
structure of foam, they do not have a particular fracture point like that of a crystalline 









Figure 3.4 Typical stress-strain curve of a biological material 
Scaffold 
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3.5.4 Biocompatibility 
Preliminary evaluation of scaffold biocompatibility was conducted by in-vitro 
culture studies. The cell seeding protocol is described below.  
The lyophilized scaffold was left in 100% ethanol for 1 hour to rehydrate the 
scaffolds. Then it was cut into 8x8x3mm cuboids and immersed in 70% ethanol 
followed by 50% ethanol each for 1 hour of continued rehydration of the scaffold. 
The scaffolds were finally washed three times with phosphate buffer solution (PBS) to 
equilibrate the pH of the scaffolds. 
The scaffolds were then left in the sterile hood for 3 hours to dry. This was 
done to ensure that all the ethanol had evaporated off as ethanol retention could kill 
the cells. The scaffolds were left overnight in sterile PBS. The following day, the 
scaffolds were left overnight in M199 culture medium for osteoblasts/bone cells at 
370C in a self-sterilizable incubator. Finally, the scaffolds were left to dry for two 
days. This was done to help the cells attach better onto the scaffolds. Just before 
seeding, the scaffolds were dampened with one drop of medium.  
The scaffolds were transferred into the bottom of 12-well plate. Porcine 
osteoblasts (Passage 3) were lifted from the bottom of a culture flask by 0.25% 
trypsin, and the cell density was adjusted to 1x105/ml by medium. Into each well 2ml 
of cell suspension was added, and the plate was transferred into the cell incubator. 24 
hours after cell seeding, medium was removed from the wells and the specimens were 
rinsed with PBS (pH7.4) for three times. Then the specimens were fixed with 3.7% 
formaldehyde and dehydrated in a graded ethanol series of 70%, 80%, 90% and 100% 
for 10 minutes each time and left to dry at room temperature. Once dry, the specimens 
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were left in an oven at 400C to remove the excess moisture. The specimens were then 
coated with gold and observed under scanning electron microscope at 10 kv. 
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Chapter 4  
The Fabrication Process 
 
4.1 Biomedical RP 
A general framework for the application of rapid prototyping in the area of 
tissue engineering is shown in Figure 4.1 [Landers et al, 2002].  A specific area of the 
patient is scanned by computer tomography (CT) or magnetic resonance (MR) and the 
data are imported into a CAD software. The scaffold is designed according to the 
individual requirements using the CAD software, and the post-processed data for the 
fabrication of the scaffold is then transferred to a RP system to produce the scaffold 
with a biocompatible and biodegradable material. Living cells are seeded onto the 
surface of the scaffold during or after the RP process. When the cell number increases 
following cell culture treatment, the scaffold is implanted into the human body and 
eventually replaced by natural tissue. 
4.1.1 3D Plotting 
A new rapid prototyping (RP) technology was reported as 3D plotting 
[Landers et al., 2002] to meet the demands for desktop fabrication of hydrogel 
scaffolds. The prototype of the 3D plotting was built on a CNC-milling machine tool 
for 3D positioning of a dispenser. It placed the dispensing process into a bath of a 
liquid with matched density. The resulting gravity force compensation allowed the 
dispensing of low-viscosity plotting materials and widened the plotting material 
spectra. Therefore a very large variety of materials could be processed, including 
melts, pastes, reactive resins or hydrogels. 
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Figure 4.1 A framework of biomedical RP [Landers et al, 2002] 
 
The basic principle of the 3D plotting is illustrated in Figure 4.2. In this 
project, a desktop rapid prototyping (RP) system was used to fabricate scaffolds using 
a principle very similar to 3D plotting (Figure 4.3). Previous project demonstrated the 
potential of the RPBOD system in fabricating 3D scaffolds with regular and 
reproducible macropore architecture [Ang et al., 2002]. 
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Figure 4.2 Basic principle of 3D plotting            Figure 4.3 RP dispensing system 
 
Although this 3D-plotting process of dispensing plotting material into a fluid 
medium has the advantages such as buoyancy support for the scaffold as it forms, a 
main disadvantage of the method is the high sensitivity to material concentration. In 
the process, the coagulation started at the gel/coagulation medium interface 
immediately upon exposure. When the gel-like precipitate was formed too quickly 
due to the high concentration of the fluid medium, there was a tendency for a 
coagulated lump to form at the nozzle. The plotting material became coagulated 
before it contacted the base layer, resulting in poor adhesion and failure to hold the 
strands down as they were dispensed, eventually leading to further clumping and 
dragging. Conversely, when the coagulation was too slow as concentration of the fluid 
medium decreased, the dispensed strands did not precipitate fast enough to hold its 
shape in the fluid medium as it tended to spread out, resulting in the merging of 
adjacent strands. Slow coagulation would also cause the possible dragging of material 
because the dispensed material spread into the path of the subsequent parallel strands 
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To eliminate the high sensitivity to medium material concentration and 
improve the scaffold fabrication process, the RPBOD system was improved for a new 
manufacture method, referred to as dual dispensing. A multiple-dispenser and a rotary 
base were added to the RP dispensing system (Figure 4.3) to develop a four-axis 
multiple-dispenser robotic system. 
4.2 The Rapid Prototyping Robotic Dispensing System 
The rapid prototyping system shown in Figure 4.4 for the fabrication of 
scaffolds is a four-axis multiple-dispenser robotic system (RPBOD) based on the Sony 
Robokits. It is capable of three simultaneous translational movements along the X-, Y- 
and Z-axis with an added rotary motion about the Z-axis. The three translational 
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There are two kinds of dispensing mechanisms: pneumatic and mechanical 
dispensing (Figure 4.5). The pneumatically driven syringe dispenser is controlled by a 
solenoid-operated pneumatic valve. The mechanical dispenser is controlled by a 
plunger driven by a stepper motor. By controlling the displacement of the plunger, the 





















Figure 4.5  Mechanical & pneumatic dispenser 
 
4.2.1  The Control Software 
The SONY RoboKids is a low-cost microprocess-based desktop robot for low 
payload. As a platform for RP dispensing system, it has been developed to be 
controlled by a PC through a serial port connection, with a developed user interface 
software to ease the operation.  
The Robokids has three levels of codes responsible for controlling it, from the 
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communication interface, to the user interface -- RPBOD software.  Robokids is 
programmable via the Sony’s Robotic LUNA Language. LUNA commands are used 
to run the various functions of the robot.  There is a special library of standard 
command functions in the SONY Robokids Programming Manual which allow the 
user to control the robot.  LUNA also allows user-specific functions to be created 
externally.  RoboDLL is the second level of codes, which is a communication 
interface to allow the use of VC++ written program to call the LUNA functions. The 
RPBOD software is the graphic user interface software written in Visual C++ to 
control the fabrication system. 
The fabrication technique offered by the RPBOD allows the generation of 
geometric data of 3D scaffolds through the control software. The geometric data are 
generated by using its slicing function to segment the 3D computer model to generate 
sliced layers to fabricate free-form customized scaffolds layer-by-layer. 
Additionally, to build simple shape scaffolds, like cubic ones, the geometrical 
data of the scaffold can be generated by simply specifying the required control 
parameters directly at a user-friendly dialog box provided by the RPBOD software.  
4.3 Cubic Scaffold Fabrication Process 
Figure 4.6 shows a part of the fabrication controls to build regular-shape 
scaffolds. To fabricate simple cubic scaffold, the length and width of the scaffold is 
set from the scaffold dimensions control box (Figure 4.6).  Other control parameters 
such as number of layers, dispensing pressure, dispensing speed and height increment 
of each layer etc. are also set in this dialog box. 
 
 





















Figure 4.6 3D scaffold fabrication controls 
The rotation centre of the base should be calibrated accurately to allow the 
edges of a layer to fall neatly over the previous layer, such that the cubic scaffold is 
able to maintain its shape. This is possible because the orientation is 90 degree to each 
other. Once the start point is set properly according to the rotation centre, the ‘edge 
wrapping’ of the scaffold is obtained, which is possible only if both the start and end 
   3D Scaffold Dispense Control Dialog 
   _________________________________________________________________________________
 Length and width of the 
cubic scaffold 
Number of layers of the 
scaffold 
Other parameters as dispensing speed and 
height increment of each layer etc 
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of the dispensed strand extend very slightly over the previous layer. Improper 
calibration of the centre will result in ragged edges of the cube. 
The position of the two dispenser tips must also be properly set. The tip of the 
NaOH dispenser must be set so that it just clears the chitosan strand in order for the 
NaOH droplet point to continuously contact the strand as it dispenses. Figure 4.7 
shows the position of the two tips. 
                                     
 
Figure 4.7 Tips position 
There are other process control parameters to be set for the fabrication. 
Among these parameters, dispensing pressure, dispensing speed and height increment 
of each layer have significant effect on the quality of the built part. An optimized set 
of parameters was picked out by single-layer experiments carried out initially. In this 
research, a pressure of 2 bars, a dispensing speed of 6mm/s and a height increment of 
3.5mm were selected.  
Figure 4.8 shows the process of scaffold fabrication, referred to as the dual 
dispensing method. During the dispensing process, the pneumatic dispenser moves 
form left to right, dispensing the chitosan gel. The following mechanical dispenser 
delivers the NaOH solution immediately to precipitate the chitosan gel. The strands 
are left on the base as the dispenser moves.  
Pneumatic 
dispenser for 
Chitosan gel  
Mechanical 
dispenser for 
NaOH solution  






(a)                                         (b)                                     (c) 
(a)                                   (b)                                         (c) 
Figure 4. 8 Scaffold fabrication process by dual dispensing 
(a) Fabrication of first layer; (b) Start of dispensing for second layer;  
(c) Scaffold building layer by layer.  
 
After the first layer, the base is rotated by 90 degrees and the dispensers are 
lifted to a higher level that allows for the chitosan gel for the next layer to be laid on 
the previous layer. The robot then generates the second layer similarly (Figure 4.8b) 
and the scaffold is progressively built as layers are sequentially generated in this 
manner (Figure 4.8c).   
4.4  3D Free-form Scaffold Fabrication 
A key advantage of the RP technology is its ability to produce complex 3D 
shape from a given computer model. To fabricate 3D free-form customized scaffold 
by the RP system, a CAD model is needed. One important step in the generation of 
CAD model is reconstructing images taken from CT/MR into 3D model of significant 
complexity and converting highly detailed medical imaging data to the data format 
that can be recognized by the rapid prototyping system. The accuracy and facility of 
this data conversion critically affect the overall utility of the scaffolds. 
Now several kinds of software in the market can act as the visualization 
medium to capture morphological data on a biological structure and to process such 
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data by a computer to generate the code required to manufacture the structure by a 
rapid prototyping equipment. In this work, the Materialise’s Interactive Medical 
Image Control System (Mimics) software was investigated for its ability of processing 
medical data.  
4.4.1  Investigation of Mimics 
Mimics is an interactive tool for the visualization and segmentation of 
CT/MRI images as well as 3D rendering of objects.  A very flexible interface to rapid 
prototyping or to CAD systems is included in the software for building distinctive 
segmentation objects. Figure 4.9 indicates the flowchart of Mimics. MedCAD and 
CTM are two modules of Mimics software. 
 
 
Figure 4.9. Mimics flowchart 
MedCAD interfaces from the medical scan data to surface files, which are 
directly usable for the design of custom made prosthesis in any CAD system. To 
verify the CAD design, the CAD 3D model can be imported into MedCAD (as an 
STL file).  The implants can be visualized in 2D cross sections on the images as well 
as in 3D model. MedCAD is designed to make a bridge between medical imaging 
(CT/MRI) and CAD design.  This means that it can export data from the imaging 
system to the CAD system and vice versa.  
Mimics 
MedCAD 
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Interpretations are made on the images in MedCAD, taking into account all 
the gray value information (soft tissue, different types of bone, tendons, etc.). On the 
images, basic features can be recognized, and converted to geometric entities (basic 
axes, reference curves, anatomical landmarks).  Only the surfaces, which are needed 
to make a fit, are actually converted to B-spline surfaces. The CAD design can also be 
imported in the MedCAD system via the STL interface.  The designs are visualized in 
2D sections together with the actual images, or in 3D shaded representations, with the 
anatomical data in a transparent mode. With this method, it is possible to bridge the 
images and the CAD system in a very short time. 
CTM interpolates the medical slice data into very thin layers, and interfaces 
directly with most rapid prototyping systems. After visualization of the image data 
that are imported into Mimics, the data can be interfaced directly with most rapid 
prototyping systems by CTM. Because of this direct interface and because of the 
higher-order interpolation mathematical algorithms, such as Bilinear and C-Spline 
functions, it produces the most accurate models in a very short time. 
As the pixel size of the input images can vary from only 0.2mm to more than 
1mm, a resolution enhancement technique is necessary when creating the RP models 
so as to minimize the effect of stair-stepping, and to retain the natural curvature of the 
surface.  Two techniques are used to increase the resolution of the contour: a bilinear 
interpolation increases the in-plane resolution of the contours with a factor of up to 
100; and an inter-plane linear interpolation of cubic alpine convolution is performed 
to decrease the slice thickness of the data set.   A slice thickness of 1 to 3mm is very 
common for the input images, whereas the slice thickness used on the RP machines is 
normally less than 0.25mm. 
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Before performing segmentation of the anatomy, the data is loaded into 
Mimics and converted into the proprietary data format of Mimics.  The image is 
processed by applying suitable threshold value to differentiate regions of interest.  
The interested tissue can be separated from other tissues by setting a fixed threshold 
value. Once visualized, the file is interfaced with CTM. CTM uses a higher-order 
interpolation algorithm to interpolate the slice data of the scan images to generate 
vertices and triangulated surfaces from the 3D models for rapid prototyping machine.  
The format exported is specific and dependent on the RP system, which includes the 
Standard Triangulation Language (STL), Initial Graphic Exchange Specification 
(IGES), Standard for the Exchange of Product Model Data (STEP), Common Layer 
Interface (CLI) and Virtual Reality Modeling Language (VRML), etc. 
4.4.2 Data processing 
Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) 
systems are the two most commonly used medical scanning systems. Through CT or 
MRI scan, a series of digitized gray-scale slice images of the scanned body is 
obtained. The purpose of the data processing is to produce 3D reconstructions of 
objects directly from the medical data and to convert the medical data to the data that 
can be processed by rapid prototyping systems. This involves separating the data of 
the tissue of interest from the scan data sets, or generating a certain part of the tissue 
from the available data. In some cases, the missing part of the tissue is extracted to 
create the implant for the scaffold building. Once certain tissue part is separated or 
created, it can be converted into data formats that are compatible with RP systems. 
The MIMICS software can also generate high-resolution 3D renderings in 
different colors directly from the slice information. Contrast enhancement can be 
carried out interactively to improve the model. Culling of the “unnecessary” parts or 
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unwanted noise is achieved with sophisticated dimensional selection and editing tools. 
Mimics also provides several segmentation techniques for processing different kinds 
of images or structures to extract interested objects. Among these techniques, 
segmentation by thresholding can be used for segmentation in CT images; 
segmentation by region growing permits the user to split an object of interest into 
several distinctive parts; recovering an ROI (Region Of Interest) makes it possible to 
recover the original (thresholded) segmentation area within specified area; 
segmentation into masks can create up to 16 different segmentation objects in one 
session; cavity fill can perform 2D or 3D fill functions. And the Boolean operations 
allow making all different kinds of combinations based on two masks. It is a very 
useful tool to reduce the work that needs to be done when separating two joints.  
In this research, a 3D computer model is derived from the CT scanned images 
using the Mimics software. Figure 4.10 shows the model of a skull generated from its 
CT scan images by Mimics.  Nearly a hundred of the CT grey value images were 
imported into Mimics and converted into Mimics’ proprietary data format. The bone 
was separated from other soft tissues by setting a suitable threshold value. Based on 
the reconstructed 3D computer model of the skull, a model of a patch has also been 
interactively created that can fill the hole on the skull by using several editing and 










Figure 4.10 The conversion of CT images to 3D computer mode by Mimics. 
4.4.3 Building Free-form Scaffold 
The model reconstructed by Mimics (Figure 4.10) was transferred in STL 
format to the RPBOD system.  Figure 4.11 shows the model displayed on the monitor 
of the RPBOD. The RPBOD software’s slicing program provides users with 
interfaces to do the following: 
1) Open and read files in STL format; 
2) Display both the STL model as well as the sliced results with some of its 3D 
operations (e.g. layer display, fit display, rotate and translate); 
3) Generate sliced layers in the +Z-direction based on user-defined scan and slice 
parameters (i.e. scan pitch (x, y) and layer thickness respectively); and 





CT images of a skull with a hole 
3D computer models of 
the skull and the patch 





Figure 4.11 Model of skull defect patch shown on the RPBOD monitor 
 
 
The model was appropriately rotated before slicing in the Z-direction. The 
information of these layers was saved as CLI file, which is a simple, efficient and 
unambiguous format for data input to fabricate the model layer-by-layer.   
Figure 4.12 show four consecutive scanned layers.  The direction of the scan 
lines is set to intersect that of the preceding layer at 90 degrees.  Hence, the built 
strands crossed at each layer to form the scaffold.  The quality of built scaffold 
depends on the characteristics of the materials and experimental conditions, including 
the concentration, dispenser speed, and dispensing rate.  
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Figure 4.12 Four consecutive layers with scan lines 
 
The built part shown in Figure 4.13 is based on the model shown in Figure 
4.11 and indicates the potential of the system to build customized free-form scaffold 
from computer model. Parameters, such as strand distance and layer height, also have 
significant effect on the quality of the built part.  
 
Figure 4.13 Chitosan scaffold of the patch built by RPBOD (15 layers) 
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Chapter 5 
Results and Discussion 
 
5.1 Results 
The chitosan scaffolds built by this dual dispensing method exhibited 
excellent uniformity and strength. This method had practically eliminated the 
occurrence of edge curling, the primary cause of strand dragging in chitosan 
scaffolding fabrication process.  Edges of scaffolds are also well defined and good 
surface uniformity of the top layer is maintained (Figure 5.1). The process has good 
reproducibility, once properly calibrated [Tan, 2002]. 
 
 
Figure 5. 1 Freshly built chitosan scaffold and the air-dried scaffold under 
optical microscope (15X) shows the uniformity of the pores 
 
Greater flexibility and advantage can be achieved with the method of dual 
dispensing with different dispensers to suit the nature of the fluid to be dispensed. The 
pneumatic dispenser extrudes the viscous gel through a small diameter (0.1 ~ 0.2 mm) 
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needle at a pressure from 2 to 4 bars, depending on the dispensing rate and the size of 
the needle.  However, when the solution is of low viscosity, it flows in an 
uncontrollable way. Therefore the pneumatic dispenser is not suitable for the 
dispensing of low-viscosity solution, such as NaOH solution.  On the other hand, the 
mechanical dispenser can achieve dispensing of low-viscosity fluids at low flow rate 
of 0.5µl/sec. Thus, the mechanical dispenser was used to dispense NaOH solution in 
the study.  
 Moreover, in the case of single dispensing of one solution into a container of 
another solution, there are the problems of gradual lowering of concentration and 
agitation of the solution in the container. These problems are eliminated in the dual 
and sequential dispensing of the solutions.  Additionally, improved adhesion is 
achieved and the operating speed is also improved since agitation of the solution that 
is dispensed into is not a problem. 
To characterize the built scaffolds, the macro-porosity and density of the 
scaffolds were measured following the method described earlier in chapter 3. The 
overall porosity of the freeze-dried scaffolds was about 90%, which is desirable to 
provide high surface area for cell polymer interactions [Freed et al., 1997]. The 
calculated apparent density of the freeze-dried chitosan scaffold was about 0.06g/ml.  
Figure 5.2 shows the morphology of the scaffold under ESEM at 15v. Macro-
pore diameters of 300-500 µm were observed which was desirably for cell growth 
into scaffolds [Lu and Mikos, 1996].  
 
 
Chapter 5 Results and Discussion 
 59
                
Figure 5. 2  ESEM picture of the surface morphology of the freeze-dried chitosan 
scaffold 
The stress-strain curves shown on Figure 5.3 were obtained from the 
compression testing results using the Instron Microtester, which was described in 
chapter 3. The values of initial compression modulus (referred to as Ei), and final 
compression modulus (referred to as Ef) were calculated from the test to evaluate the 
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The stress-strain curve of the wet scaffold is quite similar in shape to the 
typical stress-strain curve for a biological material (refer to Figure 3.4). The curve 
was obtained by compression test using the Instron Microtester with results of over a 
few hundred points. The initial compression modulus (Ei) and final compression 
modulus (Ef) can be obtained from the stress-strain curve by calculating the slops of 
the two tangents of the curve at the initial and final point, as shown in the Figure 5.3. 
The Ei and Ef for wet scaffold are about 0.013 + 0.002 MPa and 0.051+ 0.012MPa, 
while for dry scaffolds they are about 0.11+ 0.06 MPa and 0.28+ 0.06MPa. The failure 
point for the wet scaffolds is at about 0.5. The fracture point of the dry scaffolds is 
very low at about 0.25. This is due to the highly porous nature of the scaffolds. The 
strands began to break very soon after being subjected to load. 
It should be noted that the values of Ei and Ef of the chitosan scaffolds are 
generally very low and that these scaffolds should not be considered for load bearing 
applications, such as being part of knee or hip prosthesis that undergoes heavy 
compressive stresses. Fillers and additives for the chitosan gel may improve the 
material properties during fabrication. The incorporation of bioceramics such as 
hydroxyapatite (HA) into chitosan scaffolds to improve mechanical properties has 
also been reported [Ito et al., 1999; Yamaguchi et al., 2000].   
Preliminary evaluation was made by in-intro studies on the cell compatibility 
and attachment of the fabricated scaffolds. The scaffold was seeded with porcine 
osteoblasts (Passage 3). Adhesion and distribution of cells was studied via the SEM. 









Figure 5.4  SEM image shows cell compatibility and attachment. (a) shows cells 
(circled) attached on the scaffold. (b) osteoblasts adhered and spread well on the 
surface of the scaffold and kept the initial shape of polygonal 
 
Figure 5.4 is the SEM picture taken 24h after seeding. The cells can be seen to 
be attached on the scaffold surface in Figure 5.4(a) (indicated by the cycle), which is 
120 times enlarged. Though the amount of the cells is not large, it is acceptable 
considering the short time after seeding. Figure 5.4(b) is a closer view that is enlarged 
by 900 times. On this picture, osteoblasts can be observed adhering and spreading 
well on the surface of the scaffold and the initial shape of polygonal is kept, which 
indicated the good biocompatibility of the scaffold. 
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5.2 Discussion 
5.2.1 The Requirements for Tissue Engineering Scaffolds 
In order to provide a temporary substrate to which transplanted cells can 
adhere, proliferate and differentiate, both scaffold chemistry and architecture are 
important.  
The scaffolds for tissue engineering are supposed to be implanted in vivo 
which confines the viable scaffold materials to those that are non-mutagenic, non-
antigenic, non-carcinogenic, non-toxic, non-teratogenic and possess high cell/tissue 
biocompatibility as described in chapter 3. 
Besides the requirements for materials, 3D scaffolds require certain macro- 
and micro-structural properties in order to provide a suitable base for cell growth, 
apart from providing mechanical structure. The following have been identified as 
essential scaffold macro and micro-structural properties critical for rapid cell growth 
[Freed et al., 1994, Grande et al., 1993]: 
1) Macrostructure: A temporary 3D scaffold that mimics the physiological 
functions of the native ECM (extra cell matrix) is vital to maintaining the cells’ ability 
to express their native differentiated phenotypes. An optimal scaffold design will 
promote cell proliferation and cell-specific matrix production that would eventually 
take over the supporting role of the degrading scaffold. 
2) Porosity and pore interconnectivity: Scaffolds must possess an open-pore 
geometry with a highly porous surface and microstructure that allows cell in-growth 
and reorganization in vitro and provides the necessary space for neovascularization 
from surrounding tissues in vivo. The highly porous microstructure with 
interconnected porous networks is critical in ensuring spatially uniform cell 
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distribution, cell survival, proliferation and migration in vitro [LeGeros et al., 1995]. 
The scaffold’s porosity (exceeding 90%) and degree of pore interconnectivity directly 
affect the diffusion of physiological nutrients and gases to and the removal of 
metabolic waste and by-products from cells that have penetrated the scaffold [Vacanti 
et al., 1988, Mikos et al., 1993]. In larger scaffolds, high porosity and pore 
interconnectivity will enable the use of bioreactors for creating hydrodynamic 
microenvironments with minimal diffusion constraints that closely resemble natural 
interstitial fluid conditions in-vivo for achieving large and well-organized cell 
communities [Hutmacher, 2000]. 
3) Pore size: The diverse nature of tissue architectures requires different 
microenvironment for their regeneration that includes the employment of scaffolds 
with optimal pore sizes. In regenerating bone tissues in vitro, some researchers 
[Robinson et al., 1995, Boyan et al., 1996] indicated the need for pore sizes ranging 
from 200 to 400 µm, while Yoshikawa et al. [1996] successfully employed scaffolds 
with 500 µm nominal pore size. Scaffolds with pore sizes between 20 and 125 µm 
have been used for regenerating adult mammalian skin [Yannas et al., 1989] and 45–
150 µm for regenerating liver tissues [Kim et al., 1998]. When the pores employed are 
too small, pore occlusion [Rout et al., 1988] by cells will prevent cellular penetration 
and matrix elaboration within the scaffolds.  
4) Mechanical properties: As templates to guide tissue regeneration, scaffolds 
should have sufficient mechanical strength during in vitro culturing to maintain the 
spaces required for cell in-growth and matrix elaboration [Brekke, 1996]. In 
regenerating load-bearing tissues (e.g., cartilage, bone), additional issues relating to 
the scaffolds’ mechanical properties would have to be resolved [Mikos et al., 1993]. 
To allow early mobilization of the treated site, the degradable scaffold should retain 
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sufficient mechanical strength to manage any in vivo stresses and physiological 
loadings imposed on the engineered construct. The scaffolds’ degradation must be 
tuned appropriately such that it retains sufficient structural integrity until the newly 
grown tissue had replaced the scaffolds’ supporting function [Mikos et al., 1993]. 
5.2.2 Scaffold Fabricated by RPBOD System 
Since the scaffolds fabricated with the RPBOD system are to be applied in TE, 
they should satisfy the requirements for TE scaffolds. First of all, the biocompatibility 
of chitosan fulfils the requirement for the scaffold materials. Moreover, the 3D 
scaffolds show the potential for TE application by possessing the following macro- 
and micro-structural properties: 
1) Macrostructure: The 3D scaffold was fabricated with designed shape and 
interconnected pore structure, which mimics the physiological functions of the 
native ECM (extra cell matrix). 
2) Porosity:  The overall porosity of the freeze-dried scaffolds was about 90%, 
which is desirable to provide high surface area for cell polymer interactions. 
3) Pore size: The scaffold has macro-pore diameters of 300-500 µm, which was 
desirable for cell growth into scaffolds.  
4) Mechanical properties: Due to the highly porous nature of the scaffolds, the value 
of failure point for the chitosan scaffolds is generally very low. It is suitable in 
low load bearing applications. The mechanical properties may be improved by 
the incorporation of bioceramics into chitosan scaffolds. 
5.2.3 The Requirements for Scaffold Fabrication Techniques 
Based on the structural pre-requisites listed previously, one major goal in 
scaffold production is to maintain high levels of accurate control over their macro- 
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(e.g., spatial form, mechanical strength, density, porosity) and micro-structural (e.g., 
pore size, pore distribution, pore interconnectivity) properties. Although a variety of 
conventional manual-based fabrication techniques are available for scaffold 
production [Widmer and Mikos, 1998], most of them were tailored to create scaffolds 
that will meet the key requirements of specific TE applications and are not usually 
generic. Besides the fabrication techniques that largely define the scaffolds’ macro- 
and microstructure, there are a large variety of natural or synthetic scaffolding 
biomaterials to consider. Each scaffolding material or combinations of materials 
possesses different processing requirements and varying degrees of process ability to 
form scaffolds. Among the key requirements necessary to assess a fabrication 
technique for scaffold production are: [Leong et al., 2002] 
1)  Processing conditions: The material processing procedures and conditions 
should not adversely affect the material properties and subsequent clinical utility of 
the scaffolds. As such, a key requirement is that the technique should not change the 
chemical properties and biocompatibility of the scaffold nor cause any degradation in 
its mechanical properties. 
2) Process accuracy: The technique should be capable of producing spatially and 
anatomically accurate 3D scaffolds that fit the intended spaces at the implant site. 
Accuracy of the created pore sizes and morphologies as determined by the user is an 
advantage of RP technology that is difficult or sometimes impossible to achieve with 
conventional fabrication. The capability to vary and maintain accurate pore 
morphologies will enable a wide variety of scaffolds to be created to suit different TE 
applications. Having accurately constructed scaffolds will enable the application of 
computer-aided engineering (CAE) methods to perform strength and degradation 
analyses to accurately predict the scaffolds’ performance. As such, optimized scaffold 
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designs can be realized with reduced experimentation.  
3) Consistency: The technique should produce scaffolds with highly consistent 
pore sizes with a narrow size distribution range over their entire volume. In addition, 
consistency in pore characteristics, morphologies, pore distribution, pore density and 
interconnectivity in all three dimensions is required in order to produce highly regular 
3D structures. 
4) Repeatability: Different scaffold batches should exhibit minimal variations in 
physical forms and properties when produced from the same set of processing 
parameters and conditions. The technique should allow highly consistent and 
reproducible results to be achieved with ease. 
5.2.4 The Dual Dispensing Method 
The dual dispensing method provided by the four-axis RPBOD system 
presented in this research fulfills the requirements for scaffold fabrication techniques 
as flowing:  
1) Processing conditions: The RPBOD system fabricates scaffolds by extruding 
chitosan gel, which was prepared by dissolving chitosan acetic acid, forced by 
purified air during process. The material processing procedures do not change the 
chemical properties and biocompatibility of the scaffold nor cause any degradation in 
its mechanical properties. Additionally, it does not require heating and can apply 
reactive components as well as thermally sensitive bio-components into the 
fabrication process. 
2) Process accuracy: The RPBOD system is capable of three simultaneous 
translational movements along the X-, Y- and Z-axis, which have positioning 
accuracy of up to 0.05mm and a minimum step resolution of 0.014mm. As a RP 
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technology, the RPBOD system is capable of spatially and anatomically accurate 3D 
scaffolds according to the custom design. The system has the capability to vary and 
maintain accurate pore morphologies of scaffolds to suit different TE applications.  
3) Consistency: The scaffolds fabricated with the RPBOD system showed well-
defined external and internal structure. As shown in Figure 5.3, the scaffold exhibited 
the uniformity of the pores. 
4) Repeatability: The process has good reproducibility, once properly calibrated. 
It ensures that different scaffold batches exhibit minimal variations in physical forms 
and properties when produced from the same set of processing parameters and 
conditions.  
Furthermore, the dual dispensing method embodies the following additional 
advantages:  
1. It can apply a wide variety of polymer hotmelts as well as hydrogel and pastes. 
Hence, it becomes possible to control the solidification process and the 
properties of the resulting scaffold with the use of multiple materials. 
2. It does not require heating and can apply reactive components as well as 
thermally sensitive bio-components into the fabrication process. For tissue 
engineering, this means that the living cells and may be integrated into the 
scaffold material, enabling precise control and optimal conditions for tissue 
growth right from the start of fabrication. 
However, the disadvantages of the technology are the relatively slow 
processing, and time-consuming adjustment required when a new material is used to 
build scaffolds. 
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The scaffolds fabricated with the RPBOD system showed well-defined 
external and internal structure, high porosity and cell compatibility. Considering the 
requirements for TE scaffolds described above, the scaffolds fabricated are potential 
for TE application. 
In general, the advantages of the manufacture process and the properties of 
scaffold demonstrated the potential of the RPBOD system in fabricating 3D TE 
scaffolds with regular and reproducible macro-pore architecture. 
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Chapter 6 
Conclusions and Recommendations 
 
6.1 Conclusions 
A rapid prototyping robotic dispensing (RPBOD) system was used in this 
project to fabricate 3D scaffolds for tissue engineering applications. The entire system 
includes a multiple dispensing head with dual-dispensing tips for chitosan gel and 
NaOH, a rotary table and a desktop robot and is interfaced to and controlled by a 
personal computer.  
Experiments were carried out to build chitosan scaffolds using the dual 
dispensing methods provided by RPBOD system. The factors and mechanisms that 
affect the scaffold fabrication process have been investigated. Through a series of 
experiments, the dispensing parameters and concentrations that yield the best result 
were identified as a pressure of 2 bars, a dispensing speed of 6mm/s and a height 
increment of each layer of 3.5mm. A standardized protocol for preparation of the 
manufacturing materials was also drawn up: to form the chitosan gel, 3%w/v chitosan 
was dissolved in 2%v/v acetic acid; then the mixture was magnetically stirred for 2 
hours at room temperature in a beaker, the mouth of which was covered with a film 
during stirring to prevent evaporation during stirring; after that the chitosan gel was 
filtered and placed into a vacuum oven for half an hour to remove air bubbles 
introduced into the gel during stirring to make the viscous gel be completely bubble-
free for consistent extrusion. This protocol was adhered to during the experiments to 
eliminate problems due to variation of materials.  
3D free-from chitosan scaffold fabrication was based on computer model 
created from CT images, converted and extracted using the Mimics software. This 
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involves obtaining the required geometric data for the scaffold in the form of a solid 
model from CT-scan images.  The extracted scaffold model was then sliced into 
consecutive two-dimensional (2D) layers by the RPBOD software to generate 
appropriately formatted data for this rapid prototyping system to fabricate the 
scaffolds. This fabrication process shows the advantage of RP technologies in its 
ability to produce complex 3D shape from a given computer model. 
Testing and analysis of the properties of scaffolds built by RPBOD system 
were carried out. Macro-pore diameters of 300-500 µm were observed which are 
suitable for cell growth into scaffolds. The calculated overall porosity of the freeze-
dried scaffolds was about 90%, which is desirable to provide high surface area for cell 
polymer interactions. The stress-strain curves of chitosan scaffolds indicated that 
these scaffolds should be considered for use in low load bearing applications. 
Preliminary in-vitro culture studies were conducted by seeding with porcine 
osteoblasts. Adhesion and distribution of cells was studied via the scanning electron 
micrograph (SEM). Osteoblasts can be observed adhering and spreading well on the 
surface of the scaffold and the initial shape of polygonal is kept. The tests indicated 
the cell compatibility and attachment of the scaffold.  
In general, the RP robotic dispensing system (RPBOD), combining RP 
technology with tissue engineering, provides much potential for the design and 
desktop manufacturing of biomedical scaffolds. Rapid prototyping of scaffolds by the 
RPBOD is presented using a biocompatible chitosan gel. During the scaffold 
fabrication, high temperature is not required and with the multiple-dispenser feature, 
it allows fabrication with materials or material additives, which otherwise decompose 
under heat, as well as the incorporation of proteins and living cells. The high porosity 
of the resulting scaffolds can be obtained to facilitate good ventilation and cell growth. 
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6.2 Recommendations 
As a continuation to this work, the following recommendations are made for 
future research to further develop the RPBOD system for tissue engineering 
applications. 
1. In-vivo experiments can be carried out to study the tissue compatibility in the 
body. This is because materials do not behave in the same manner inside and 
outside the body. 
2. Post-processing for the chitosan scaffolds, such as leaching [Lu et al., 2000], 
may be conducted to change the smooth surface of the hydrogel strands and 
generate a rougher surface in order to improve the cell attachment.   
3. Modify the algorithm for dual dispensing to generate more patterns of scaffold 
strands, (e.g. the strands in orientations of 60 degrees) to investigate the effect 
of different orientations of adjacent layers on the strength and structure of the 
scaffolds, as well as the cell cultivation.    
4. Fabricate other regularly-shaped scaffolds, like cylindrical, other than the 
current cubic scaffolds to increase the variety of scaffolds. 
5. With multiple dispensing capabilities, different multiple-feeding 3D-
dispensing techniques using various materials can now be investigated. A 
particularly interesting area is the use of fibrinogen and thrombin, which 
require precise low flow rates and simultaneous-dispensing capabilities.  
6. Instigate the incorporation of cell seeding into the 3D dispensing plotting 
materials.   
7. Improvements regarding the mechanical properties are necessary. Fillers and 
additives for the chitosan gel may improve the material properties during 
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fabrication. The tacky, high-viscosity gel that is used now is difficult to 
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Figure A.1 RoboKids dimensions 
 
Table A.1 Machine specifications 
Item X-axis Y-axis Z-axis 
Work envelope 250mm 210mm 70mm 
Maximum speeds 300mm/s 300mm/s 100mm/s 
Pose-repeatability 
(Positioning accuracy) ±0.05mm ±0.05mm ±0.05mm 
Maximum payload - 5kg 2kg 
Resolution 0.014mm 0.014mm 0.014mm 
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Appendix B. Materials Information  
 
 
Physical/Chemical Characteristics of Chitosan: 
 
Appearance and odor – Chitosan is fine, odorless and tasteless powder manufacturing 
from crab shells. 
 
Solubility –  Insoluble in water and alcohols; soluble in dilute organic acids. 
 
 
Chitosan, 50g  
Catalog#  UOM  Product Size  
4-00022 EA   50g   
 
Details 
Appearance: High Purity Powder 
Ash: <1.0% 
CAS Number: [9012-76-4] 
Molecular Formula: C12H24N2O9 
Molecular Weight: 340.32 
Particle Size: <0.2 mm 
Source: from crab shells 
Substance Name: Chitosan 
Supplier Name: CarboMer, Inc. 
   
Category UNSPSC: 12-21-21-00   
 
Figure B.1 Chitosan information sheet from vendor (Carbomer, Inc. USA) 
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Appendix C. Macro- porosity Calculation 
 
 
The macro-porosity of the scaffolds was measured following the protocol stated in 
chapter 3.5.2. A sample of scaffold of weigh W was immersed in a graduated cylinder 
containing a known volume (V1) of ethanol. The sample will then kept in the ethanol for 
5 minutes and then a series of brief evacuation – repressurization cycles will be 
conducted to force the ethanol into pores and continued until no sir bubbles emerged 
from the scaffolds. The new volume was recorded a V2. The volume difference (V2-V1) 
is the volume of the scaffold. The scaffold will be removed and the residual ethanol 
volume was recorded as V3. The total volume (V) of the composite scaffold was (V2 – 
V3). The density was W/ (V2-V3). The Porosity was (V1-V3)/ (V2-V3). 
Each time, three samples were used in the calculation. Triplicate experiments under 
room temperature were performed for each sample and a standard deviation of the results 
was calculated to determine the statistical significance of the differences in porosity.  
 
Table C.1 Sample of macro- porosity calculation. 
 
Sample  S1 S2 S3 
W(g) 0.0061  0.0066 0.0070  
V1(ml) 0.48 0.65 0.61 
V2(ml) 0.49 0.66 0.62 
V3(ml) 0.4 0.55 0.51 
V2-V1 0.01 0.01 0.01 
V2-V3 0.09 0.11 0.11 
V1-V3 0.08 0.1 0.1 
Density( g/ml)  0.067778 0.06 0.062727 
Porosity 0.88889 0.90909 0.90909 
Average Porosity 0.90 
Standard Deviation of Porosity 0 
 
